8th Mar 2021 15:05
Ap19
FORM 8.3 - Amendment to sales and purchase
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. | |
Company dealt in | WILLIS TOWERS WATSON PLC | |
Class of relevant security to which the | ORD | |
dealings being disclosed relate (Note 2) | ||
Date of dealing | 04 March 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
1,852,191 | 1.44% | 230,975 | 0.18% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
103,127 | 0.08% | 7,066 | 0.01% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
purchase/sell: | 6,100 | 0.00% | 6,100 | 0.00% | |
|
|
|
| ||
TOTAL: |
|
|
|
| |
1,961,418 | 1.52% | 244,141 | 0.19% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
|
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 1 | 222.2400 USD |
Purchase | 1 | 222.0400 USD |
Purchase | 3 | 222.2266 USD |
Purchase | 3 | 221.9700 USD |
Purchase | 4 | 220.2200 USD |
Purchase | 4 | 222.1775 USD |
Purchase | 10 | 222.5500 USD |
Purchase | 11 | 222.9309 USD |
Purchase | 16 | 222.4500 USD |
Purchase | 26 | 222.1800 USD |
Purchase | 34 | 220.9800 USD |
Purchase | 48 | 221.9950 USD |
Purchase | 85 | 223.3800 USD |
Purchase | 100 | 222.4900 USD |
Purchase | 100 | 222.2500 USD |
Purchase | 200 | 222.3300 USD |
Purchase | 200 | 221.5325 USD |
Purchase | 200 | 222.9500 USD |
Purchase | 224 | 221.9511 USD |
Purchase | 244 | 221.0859 USD |
Purchase | 250 | 220.9250 USD |
Purchase | 259 | 221.7531 USD |
Purchase | 287 | 223.2266 USD |
Purchase | 425 | 221.4831 USD |
Purchase | 584 | 221.5876 USD |
Purchase | 1,258 | 221.8903 USD |
Purchase | 2,312 | 221.8267 USD |
Purchase | 3,900 | 220.3358 USD |
Purchase | 4,184 | 222.0434 USD |
Purchase | 4,471 | 222.0080 USD |
Purchase | 8,012 | 221.2278 USD |
Purchase | 9,791 | 222.0423 USD |
Purchase | 14,512 | 221.9340 USD |
Purchase | 28,557 | 222.1106 USD |
Purchase | 105,663 | 221.9500 USD |
Sale | 1 | 224.0500 USD |
Sale | 2 | 222.1750 USD |
Sale | 6 | 222.1100 USD |
Sale | 11 | 221.6600 USD |
Sale | 12 | 220.3400 USD |
Sale | 52 | 222.1800 USD |
Sale | 68 | 223.3447 USD |
Sale | 80 | 221.8410 USD |
Sale | 84 | 220.9800 USD |
Sale | 100 | 220.7300 USD |
Sale | 100 | 222.9500 USD |
Sale | 158 | 221.7601 USD |
Sale | 161 | 221.6849 USD |
Sale | 200 | 220.2600 USD |
Sale | 208 | 221.3697 USD |
Sale | 242 | 222.5122 USD |
Sale | 300 | 220.3033 USD |
Sale | 352 | 221.9576 USD |
Sale | 500 | 221.0984 USD |
Sale | 563 | 222.5650 USD |
Sale | 710 | 222.3112 USD |
Sale | 812 | 221.7177 USD |
Sale | 935 | 221.4445 USD |
Sale | 1,026 | 221.8391 USD |
Sale | 1,158 | 221.9905 USD |
Sale | 1,209 | 221.5418 USD |
Sale | 1,984 | 222.2813 USD |
Sale | 3,085 | 222.0947 USD |
Sale | 3,335 | 222.3353 USD |
Sale | 3,400 | 220.3431 USD |
Sale | 4,893 | 221.9500 USD |
Sale | 4,937 | 221.9242 USD |
Sale | 6,974 | 221.2372 USD |
Sale | 7,611 | 222.0136 USD |
Sale | 9,791 | 222.0423 USD |
Sale | 13,826 | 221.9606 USD |
Sale | 14,319 | 222.0980 USD |
Sale | 50,243 | 221.9502 USD |
Sale | 51,675 | 221.9459 USD |
(b) Derivatives transactions (other than options transactions)
Product Name | Nature of transaction | Number of relevant securities | Price per |
unit | |||
SWAP | Long | 71,000 | 221.9500 USD |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 (Open Positions) attached? | YES |
Date of disclosure: | 8 Mar 2021 |
Contact name: | Large Holdings Regulatory Operations |
Telephone number: | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected | |
If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name | Written or | Number of | Exercise | Type | Expiry |
purchased | relevant securities | price | date | ||
to which the option | |||||
or derivative | |||||
relates | |||||
Put Options | Purchased | -100 | 220.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 100 | 240.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210308005597/en/
Copyright Business Wire 2021
Related Shares:
Barclays